Lava Therapeutics competitorsClear all

Lava Therapeutics's top competitors include Viosera Therapeutics, Shanghai Henlius Biotech, Cellectar Biosciences and Agenus.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Lava Therapeutics
Lava Therapeutics
Lava Therapeutics is a biotech company that develops T-cell engagers for the therapy of solid tumors and hematologic malignancies.
Viosera Therapeutics
Viosera Therapeutics
Viosera Therapeutics is a company developing combination therapies for infections and cancer.
Shanghai Henlius Biotech
Shanghai Henlius Biotech
Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services.
Cellectar Biosciences
Cellectar Biosciences
Cellectar Biosciences is a clinical stage biopharmaceutical company that engages in the development of targeted phospholipid drug conjugates for the treatment and imaging of cancer.
Agenus
Agenus
Agenus is a clinical-stage immuno-oncology company which focuses on the discovery and development of therapies that engage the body's immune system for patients suffering with cancer.
Founding Date
Founding Date
2016
Founding Date
2016
Founding Date
2009
Founding Date
1996
Founding Date
1994
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Utrecht, NL HQ
Philadelphia, US
Locations
Overland, US HQ
Locations
HQ
Locations
Madison, US HQ
Florham Park, US
Locations
Lexington, US HQ
Cambridge, GB
Berkeley, US
New York, US
Employees
Employees
28
Employees
4
Employees
1273% increase
Employees
753% decrease
Employees
32812% increase
Valuation ($)
Valuation ($)
176.8 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
47.4 m
Valuation ($)
820.8 m
Twitter followers
Twitter followers
86
Twitter followers
54
Twitter followers
N/A
Twitter followers
659
Twitter followers
2.2 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
25
Number of tweets (last 30 days)
10
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.4
Average likes per tweet (last 30 days)
13.8
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
87.5%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
334939
Alexa Website Rank
N/A
Alexa Website Rank
295832
Alexa Website Rank
600994
Alexa Website Rank
246985
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3.5
Employee Rating
N/A
Employee Rating
3.5

Financial

Revenue (est.)
Revenue (est.)
€3.2m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$88.2m (FY, 2020)
Net income
Net income
(€13.6m) (FY, 2020)
Net income
N/A
Net income
N/A
Net income
($15.1m) (FY, 2020)
Net income
($182.9m) (FY, 2020)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 150k (over 2 years ago)
Latest funding round
$ 156m (over 3 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 102.8m
Total funding raised
$ 150k
Total funding raised
$ 346m
Total funding raised
N/A
Total funding raised
$ 171.1m
For sources of this data, please see the company profile

View company profiles

Viosera Therapeutics
HQ
Overland, US
Employees
4

Viosera Therapeutics is a company developing combination therapies for infections and cancer.

View company
Shanghai Henlius Biotech
HQ
Employees
127↑ 3% increase

Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services.

View company
Cellectar Biosciences
HQ
Madison, US
Employees
7

Cellectar Biosciences is a clinical stage biopharmaceutical company that engages in the development of targeted phospholipid drug conjugates for the treatment and imaging of cancer.

View company
Agenus
HQ
Lexington, US
Employees
328↑ 12% increase

Agenus is a clinical-stage immuno-oncology company which focuses on the discovery and development of therapies that engage the body's immune system for patients suffering with cancer.

View company